Treace Medical Concepts (TMCI) Research & Development (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Research & Development data on file, last reported at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 16.9% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $19.3 million (down 7.42% YoY), and the FY2025 full-year result was $20.3 million, down 1.49% from the prior year.
• Research & Development for Q1 2026 stood at $4.6 million, up from $4.5 million in the prior quarter.
• Across five years, Research & Development topped out at $5.6 million in Q1 2025 and bottomed at $3.0 million in Q2 2022.
• The 5-year median for Research & Development is $4.5 million (2025), against an average of $4.4 million.
• The widest annual swing landed in 2022, when Research & Development soared 63.38%; it then decreased 16.9% in 2026.
• A 5-year view of Research & Development shows it stood at $3.7 million in 2022, then gained by 10.75% to $4.2 million in 2023, then climbed by 25.48% to $5.2 million in 2024, then fell by 12.82% to $4.5 million in 2025, then grew by 1.76% to $4.6 million in 2026.
• The last three Research & Development figures came in at $4.6 million (Q1 2026), $4.5 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison